Algorhythm Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, disclosing a net loss of $27,297,000 for the nine months ended on that date, alongside significant balance sheet changes driven by acquisitions and impairment charges.
Key Highlights
- Net loss of $27,297,000 for the nine months ended September 30, 2026, compared to a net loss of $13,085,000 in the same period of 2025, according to the filing.
- Net sales of $7,494,000 for the nine months ended September 30, 2026, up from $3,018,000 in the comparable prior-year period, the company reported.
- Goodwill impairment of $1,896,000 and long-lived assets impairment of $1,322,000 were recorded in the three months ended September 30, 2026, per the filing.
- Total assets increased to $25,249,000 at September 30, 2026, from $12,724,000 at December 31, 2025, with goodwill rising to $15,659,000 from $2,682,000.
- Common shares outstanding rose to 33,625,396 at September 30, 2026, from 3,414,542 at December 31, 2025, the filing disclosed.
- Cash declined to $406,000 at September 30, 2026, from $1,632,000 at December 31, 2025, according to the balance sheet.
- Accumulated deficit reached $90,999,000 at September 30, 2026, compared to $65,043,000 at December 31, 2025, per the filing.
Algorhythm Holdings Reports Wide Losses and Balance Sheet Expansion in Third Quarter 2026
Algorhythm Holdings, Inc. (NASDAQ:RIME), a Delaware-incorporated company headquartered in Fort Lauderdale, Florida, filed its quarterly report covering the period ended September 30, 2026. According to the filing, the company reported a gross loss of $2,391,000 on net sales of $7,494,000 for the nine-month period, with cost of sales of $9,885,000 exceeding revenue. For the three months ended September 30, 2026, net sales were $2,089,000 against cost of sales of $3,210,000, producing a quarterly gross loss of $1,121,000.
The filing disclosed total operating expenses of $21,925,000 for the nine months ended September 30, 2026, including general and administrative expenses of $18,571,000, goodwill impairment of $1,896,000, and long-lived assets impairment of $1,322,000. Loss from operations for the nine-month period was reported at $24,316,000. Additional other expenses included interest expense, net, of $2,475,000 and loss on debt extinguishment of $503,000, bringing total other expenses to $2,978,000 for the nine months ended September 30, 2026.
On the balance sheet, total liabilities stood at $19,635,000 at September 30, 2026, up from $14,584,000 at December 31, 2025. Promissory notes payable, net, were $10,011,000, and notes payable to related parties in default were $1,962,000, as reported in the filing. Accrued expenses increased to $6,137,000 from $1,556,000. The company also disclosed 22,038 shares of preferred stock issued and outstanding at September 30, 2026, with a deemed dividend on exchange of series A preferred stock of $525,000 and a preferred return on series A preferred stock of $79,000 during the period. As of November 16, 2026, the filing stated there were 40,898,979 shares of common stock outstanding.
What Was Disclosed
Algorhythm Holdings filed its 10-Q for the quarter ended September 30, 2026, reporting a nine-month net loss of $27,297,000, an accumulated deficit of $90,999,000, significant impairment charges, and a substantial increase in goodwill and common shares outstanding relative to December 31, 2025.





Please wait processing your request...